Leuven

• A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden … Pending
  2025-523259-72-00 5 Hidradenitis Suppurativa (HS)
• A phase 2, single arm, open label, study on the safety and feasibility of Liver Isolated Oxaliplatin (LIOX) delivered via arterial access de … Pending
  2025-523261-25-00 4 colorectal cancer
• Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending
  2025-523400-72-00 4 Cystic fibrosis
• A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients with Advanced KRAS … Pending
  2025-523432-39-01 9 Advanced KRAS G12D-Mutant Solid Tumors
• Rollover study for participants who are currently being treated with and are continuing to benefit from opnurasib as a single agent or in co … Pending
  2025-523537-26-00 9 Locally advanced or metastatic KRAS G12C-mutated non-small cell lung c
• Phase II study of ezabenlimab in patients with PD-L1-positive head and neck cancer with residual disease detected by ctDNA after chemoradiot … Pending
  2025-523575-36-00 4 Locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat … Pending
  2025-523735-19-00 5 Metastatic Microsatellite Stable Colorectal Cancer
• Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome Pending
  2025-523835-20-00 7 Dravet Syndrome
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• A Study of Enpatoran in Cutaneous Manifestations of Lupus With or Without Systemic Disease Pending
  2025-523871-44-00 5 Cutaneous Manifestations of Lupus Erythematosus With or Without System
• J6Z-MC-IIBD - A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn’s Disease J6Z-MC-CD01 - A Stud … Pending
  2025-524112-11-00 4 J6Z-MC-IIBD - Colitis, Ulcerative Crohn Disease J6Z-MC-CD01 - Crohn
• Colonic Intramural Injections of Botulin toxin versus placebo to treat fragmented defecation and urgency after restorative total mesorectal … Pending
  2025-524342-96-00 4 Rectal Cancer
• A PET Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants Pending
  2025-524564-38-00 3 Neuropsychiatric indications and potentially other conditions
• A Research Study Testing New Cancer Medicines Used Alone or Together to Treat Solid Tumors Pending
  2025-524623-50-00 9 Solid Tumors
• Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combination for Inflammatory Bowel Disease Pending
  2025-524640-35-00 4 Ulcerative colitis (Inflammatory Bowel Disease)
• Shorter versus longer antibiotic treatment for serious urinary tract infections in men Pending
  2025-524703-76-00 5 Urinary tract infection with systemic involvement (UTI: definite, prob
• Phase 2a Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis Pending
  2025-524784-20-00 4 Recurrent Pericarditis
• ENDO-REAL: Endometriosis and Reproductive Enhancement with Letrozole Pending
  2025-524995-53-00 6 Women with endometriosis undergoing IVF/ICSI
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• Randomized Evaluation of fleCAinide safety vs. STandard of care in patients with coronary artery disease and Atrial Fibrillation (ReCAST AF) … Pending
  2025-525121-13-00 6 Coronary artery disease
• A Phase 2, Open-Label Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the S … Pending
  2025-525124-10-00 4 Duchenne Muscular Dystrophy
• Safety and Tolerability of REGN17235 in Adult Participants with Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic S … Pending
  2026-525464-18-00 1 Clonal Cytopenia of Undetermined Significance with SF3B1 mutation
• The impact of beta-blocker therapy on quality of life and rehabilitation outcomes in patients after myocardial infarction with preserved eje … Pending
  2026-525475-96-00 6 Myocardial infarction with preserved ejection fraction
• A neuropsychobiological approach to optimize patient selection for GLP-1-based pharmacotherapy for weight management across the binge eating … Pending
  2026-526016-36-00 6 obesity

Showing 49–72 of 1,145 trials